A detailed history of Bridgefront Capital, LLC transactions in Cabot Corp stock. As of the latest transaction made, Bridgefront Capital, LLC holds 2,562 shares of CBT stock, worth $256,430. This represents 0.11% of its overall portfolio holdings.

Number of Shares
2,562
Holding current value
$256,430
% of portfolio
0.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$86.96 - $111.73 $222,791 - $286,252
2,562 New
2,562 $286,000
Q1 2024

May 15, 2024

BUY
$71.14 - $92.2 $299,357 - $387,977
4,208 New
4,208 $387,000
Q2 2022

Aug 12, 2022

BUY
$60.56 - $78.03 $327,326 - $421,752
5,405 New
5,405 $345,000
Q1 2021

May 17, 2021

SELL
$43.84 - $54.11 $201,006 - $248,094
-4,585 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$36.29 - $44.88 $166,389 - $205,774
4,585 New
4,585 $206,000

Others Institutions Holding CBT

About CABOT CORP


  • Ticker CBT
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 56,299,200
  • Market Cap $5.63B
  • Description
  • Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company offers reinforcing carbons used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such...
More about CBT
Track This Portfolio

Track Bridgefront Capital, LLC Portfolio

Follow Bridgefront Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgefront Capital, LLC with notifications on news.